Titre : Menthol

Menthol : Questions médicales fréquentes

Termes MeSH sélectionnés :

Quantitative Structure-Activity Relationship
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Menthol : Questions médicales les plus fréquentes", "headline": "Menthol : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Menthol : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-15", "dateModified": "2025-04-11", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Menthol" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Cyclohexanols", "url": "https://questionsmedicales.fr/mesh/D003511", "about": { "@type": "MedicalCondition", "name": "Cyclohexanols", "code": { "@type": "MedicalCode", "code": "D003511", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.289.510.500" } } }, "about": { "@type": "MedicalCondition", "name": "Menthol", "alternateName": "Menthol", "code": { "@type": "MedicalCode", "code": "D008610", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Joanna E Cohen", "url": "https://questionsmedicales.fr/author/Joanna%20E%20Cohen", "affiliation": { "@type": "Organization", "name": "Institute for Global Tobacco Control, Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States." } }, { "@type": "Person", "name": "Dorothy K Hatsukami", "url": "https://questionsmedicales.fr/author/Dorothy%20K%20Hatsukami", "affiliation": { "@type": "Organization", "name": "Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA." } }, { "@type": "Person", "name": "Michael Kotlyar", "url": "https://questionsmedicales.fr/author/Michael%20Kotlyar", "affiliation": { "@type": "Organization", "name": "Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, USA." } }, { "@type": "Person", "name": "Ryan Shanley", "url": "https://questionsmedicales.fr/author/Ryan%20Shanley", "affiliation": { "@type": "Organization", "name": "Biostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA." } }, { "@type": "Person", "name": "Sheena R Dufresne", "url": "https://questionsmedicales.fr/author/Sheena%20R%20Dufresne", "affiliation": { "@type": "Organization", "name": "Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Quantitative Structure Retention-Relationship Modeling: Towards an Innovative General-Purpose Strategy.", "datePublished": "2023-02-10", "url": "https://questionsmedicales.fr/article/36838689", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/molecules28041696" } }, { "@type": "ScholarlyArticle", "name": "Predictive Quantitative Read-Across Structure-Property Relationship Modeling of the Retention Time (Log", "datePublished": "2023-06-09", "url": "https://questionsmedicales.fr/article/37294004", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.jafc.3c01438" } }, { "@type": "ScholarlyArticle", "name": "Modeling of Anticancer Sulfonamide Derivatives Lipophilicity by Chemometric and Quantitative Structure-Retention Relationships Approaches.", "datePublished": "2022-06-21", "url": "https://questionsmedicales.fr/article/35807212", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/molecules27133965" } }, { "@type": "ScholarlyArticle", "name": "Exploring structure-activity relationships for polymer biodegradability by microorganisms.", "datePublished": "2023-05-19", "url": "https://questionsmedicales.fr/article/37211122", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.scitotenv.2023.164338" } }, { "@type": "ScholarlyArticle", "name": "Exploring quantitative structure-property relationship models for environmental fate assessment of petroleum hydrocarbons.", "datePublished": "2022-11-10", "url": "https://questionsmedicales.fr/article/36355241", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11356-022-23904-x" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Lipides", "item": "https://questionsmedicales.fr/mesh/D008055" }, { "@type": "ListItem", "position": 3, "name": "Alcools gras", "item": "https://questionsmedicales.fr/mesh/D005233" }, { "@type": "ListItem", "position": 4, "name": "Hexanols", "item": "https://questionsmedicales.fr/mesh/D000441" }, { "@type": "ListItem", "position": 5, "name": "Cyclohexanols", "item": "https://questionsmedicales.fr/mesh/D003511" }, { "@type": "ListItem", "position": 6, "name": "Menthol", "item": "https://questionsmedicales.fr/mesh/D008610" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Menthol - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Menthol", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Menthol", "description": "Comment le menthol est-il détecté dans les produits ?\nQuels tests sont utilisés pour évaluer la sensibilité au menthol ?", "url": "https://questionsmedicales.fr/mesh/D008610?mesh_terms=Quantitative+Structure-Activity+Relationship&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Menthol", "description": "Quels symptômes peuvent indiquer une allergie au menthol ?\nLe menthol peut-il provoquer des maux de tête ?", "url": "https://questionsmedicales.fr/mesh/D008610?mesh_terms=Quantitative+Structure-Activity+Relationship&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Menthol", "description": "Comment éviter les réactions allergiques au menthol ?\nLe menthol peut-il être utilisé en prévention des infections ?", "url": "https://questionsmedicales.fr/mesh/D008610?mesh_terms=Quantitative+Structure-Activity+Relationship&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Menthol", "description": "Comment le menthol est-il utilisé pour soulager la douleur ?\nLe menthol est-il efficace contre la toux ?", "url": "https://questionsmedicales.fr/mesh/D008610?mesh_terms=Quantitative+Structure-Activity+Relationship&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Menthol", "description": "Quelles complications peuvent survenir avec une surconsommation de menthol ?\nLe menthol peut-il aggraver l'asthme ?", "url": "https://questionsmedicales.fr/mesh/D008610?mesh_terms=Quantitative+Structure-Activity+Relationship&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Menthol", "description": "Qui est à risque d'allergie au menthol ?\nLe menthol est-il risqué pour les enfants ?", "url": "https://questionsmedicales.fr/mesh/D008610?mesh_terms=Quantitative+Structure-Activity+Relationship&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment le menthol est-il détecté dans les produits ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le menthol est détecté par chromatographie en phase gazeuse ou spectrométrie de masse." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la sensibilité au menthol ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests cutanés ou des évaluations de la douleur peuvent être utilisés pour mesurer la sensibilité." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer une allergie au menthol ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des démangeaisons, rougeurs ou éruptions cutanées peuvent survenir en cas d'allergie." } }, { "@type": "Question", "name": "Le menthol peut-il provoquer des maux de tête ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent ressentir des maux de tête après exposition au menthol." } }, { "@type": "Question", "name": "Comment éviter les réactions allergiques au menthol ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les produits contenant du menthol si vous avez des antécédents d'allergies." } }, { "@type": "Question", "name": "Le menthol peut-il être utilisé en prévention des infections ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Le menthol a des propriétés antimicrobiennes, mais ne remplace pas les traitements médicaux." } }, { "@type": "Question", "name": "Comment le menthol est-il utilisé pour soulager la douleur ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Le menthol est appliqué localement pour créer une sensation de froid, réduisant ainsi la douleur." } }, { "@type": "Question", "name": "Le menthol est-il efficace contre la toux ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le menthol est souvent utilisé dans les sirops pour apaiser la toux et les irritations." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une surconsommation de menthol ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Une surconsommation peut entraîner des irritations cutanées ou des troubles gastro-intestinaux." } }, { "@type": "Question", "name": "Le menthol peut-il aggraver l'asthme ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Chez certaines personnes, le menthol peut provoquer des spasmes bronchiques et aggraver l'asthme." } }, { "@type": "Question", "name": "Qui est à risque d'allergie au menthol ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant des antécédents d'allergies cutanées ou respiratoires sont à risque." } }, { "@type": "Question", "name": "Le menthol est-il risqué pour les enfants ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent être plus sensibles aux effets du menthol, nécessitant prudence." } } ] } ] }

Sources (10000 au total)

Quantitative Structure Retention-Relationship Modeling: Towards an Innovative General-Purpose Strategy.

Reversed-Phase Liquid Chromatography (RPLC) is a common liquid chromatographic mode used for the control of pharmaceutical compounds during their drug life cycle. Nevertheless, determining the optimal...

Modeling of Anticancer Sulfonamide Derivatives Lipophilicity by Chemometric and Quantitative Structure-Retention Relationships Approaches.

Sulfonamides are a classic group of chemotherapeutic drugs with a broad spectrum of pharmacological action, including anticancer activity. In this work, reversed-phase high-performance liquid chromato...

Exploring quantitative structure-property relationship models for environmental fate assessment of petroleum hydrocarbons.

The rate and extent of biodegradation of petroleum hydrocarbons in the different aquatic environments is an important element to address. The major avenue for removing petroleum hydrocarbons from the ...

"Data fusion" quantitative read-across structure-activity-activity relationships (q-RASAARs) for the prediction of toxicities of binary and ternary antibiotic mixtures toward three bacterial species.

Antibiotics are often found in the environment as pollutants. They are usually found as mixtures in the environment and may produce toxicity against different ecological species due to joint exposure ...

A data reusability assessment in the nanosafety domain based on the NSDRA framework followed by an exploratory quantitative structure activity relationships (QSAR) modeling targeting cellular viability.

The current effort towards the digital transformation across multiple scientific domains requires data that is Findable, Accessible, Interoperable and Reusable (FAIR). In addition to the FAIR data, wh... To address this challenge, we utilized 34 datasets from the nanosafety domain by exploiting the NanoSafety Data Reusability Assessment (NSDRA) framework, which allowed the annotation and assessment of... Universal regression and classification QSARs reached an 0.86 R... This study reveals that the digitalization of nanosafety knowledge in a reproducible manner has a long way towards its successful pragmatic implementation. The workflow carried out in the study shows ...

Density Functional Theory and Machine Learning-Based Quantitative Structure-Activity Relationship Models Enabling Prediction of Contaminant Degradation Performance with Heterogeneous Peroxymonosulfate Treatments.

Heterogeneous peroxymonosulfate (PMS) treatment is recognized as an effective advanced oxidation process (AOP) for the treatment of organic contaminants. Quantitative structure-activity relationship (...

Systematic computational toxicity analysis of the ozonolytic degraded compounds of azo dyes: Quantitative structure-activity relationship (QSAR) and adverse outcome pathway (AOP) based approach.

The present study identifies and analyses the degraded products of three azo dyes (Reactive Orange 16, Reactive Red 120, and Direct Red 80) and proffers their in silico toxicity predictions. In our pr...